Biomedical subjects

Qi Wu

Publications and source records attributed to Qi Wu.

5 recordsLinked to original sources

PubMed2026

Evolutionary constraints and regulatory plasticity shape host specialization in the Magnaporthe oryzae species complex.

Rice blast caused by Magnaporthe oryzae threatens global rice production, and wheat blast emergence highlights the pathogen's capacity for host shifts. Although numerous studies have described M. oryzae genome organization and infection mechanisms, critical questions remain regarding the evolutionary drivers of stable host specialization. Importantly, the blast pathogen comprises a species complex of genetically differentiated, host-adapted lineages rather than single homogeneous species. To address this knowledge gap, we integrate evidence from evolutionary genomics, transcriptomics, and metabolomics to develop the "Constrained Plasticity" framework. We argue that host adaptation arises from three interacting layers: genomic scaffolding (including epigenetic and noncoding RNA regulation), regulatory networks (enabling transcriptional plasticity), and metabolic compatibility (determining physiological success). This systems-level perspective explains the long-term stability of host-adapted lineages and the rare breakdowns resulting in host shifts, such as wheat blast. This framework generates testable predictions for pathogen emergence and provides a roadmap for developing lineage-aware resistance strategies.

Oryza↗

PubMed2026

Sodium-glucose cotransporter-2 inhibitors and gastrointestinal neoplasm risk in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.

The potential carcinogenic effects of sodium-glucose cotransporter 2 (SGLT2) inhibitors in patients with type 2 diabetes mellitus (T2DM) remain controversial, particularly regarding site-specific gastrointestinal (GI) neoplasms. This systematic review and meta-analysis aimed to determine the relationship between SGLT2 inhibitors and the risk of GI neoplasms in patients with T2DM. We searched PubMed, EMBASE, Cochrane CENTRAL, Scopus, and Web of Science through March 17, 2025, for RCTs in T2DM comparing SGLT2 inhibitors with placebo or active comparators. Two reviewers independently screened studies, extracted data, and assessed the risk of bias. The primary outcome was GI neoplasms reported in publications, supplementary materials, or trial registries, usually as adverse events rather than centrally adjudicated cancer endpoints. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated in Stata 17.0. In 48 RCTs (n = 48,765), SGLT2 inhibitor therapy was not associated with overall GI neoplasm risk (OR = 1.10, 95% CI: 0.84-1.44; p = 0.46; I² = 0%). Site-specific analyses showed no statistically significant association for esophageal (OR = 1.12, 95% CI 0.37-3.45), gastric (1.20, 0.65-2.23), hepatic (0.62, 0.31-1.22), pancreatic (0.91, 0.51-1.64), colonic (1.28, 0.78-2.08), colorectal (0.76, 0.27-2.17), and rectal neoplasms (0.98, 0.49-1.97), with all p-values > 0.05. Subgroup analyses by agents (e.g., canagliflozin, dapagliflozin, empagliflozin), baseline age, body mass index (BMI), HbA1c, treatment duration, and dose were also non-significant (all p > 0.05). Approximately half of the trials had follow-up of one year or less, limiting our ability to evaluate long-term risk. Available RCT evidence does not show a clear increase in GI neoplasm risk with SGLT2 inhibitors in T2DM. However, limited follow-up, low event counts, and non-cancer-specific outcome ascertainment, the findings should be interpreted as reassuring but not definitive evidence of long-term oncologic safety.Systematic review registration: PROSPERO No. CRD42024619019.

Humans↗

PubMed2026

A geroprotective probiotic and its functional metabolite counteract inflammaging to extend healthspan.

The gut microbiome profoundly influences host aging, yet the specific microbes and mechanisms governing divergent aging trajectories remain elusive. In this study, we delineated enterotype-specific gut microbial remodeling during aging and developed a microbiome-based aging clock (MicroAge) to track biological aging trajectories. We identified Bifidobacterium pseudocatenulatum (B. pseudocatenulatum) as a candidate geroprotective species consistently depleted during aging across both sexes and multiple Chinese cohorts. In naturally aged mice, oral B. pseudocatenulatum monotherapy rescued intestinal homeostasis, mitigated multiorgan inflammaging, enhanced cognitive-motor performance and extended healthspan. Mechanistically, we characterized 5-aminovaleric acid betaine (5-AVAB) as a key B. pseudocatenulatum-derived metabolite whose levels decline physiologically in aging humans. 5-AVAB supplementation partially recapitulated a broad spectrum of the systemic benefits observed with B. pseudocatenulatum treatment, including improved cognitive and motor function and suppressed multiorgan inflammaging. Our findings identify the B. pseudocatenulatum-5-AVAB axis as a promising target for microbiome-based interventions to promote healthy aging.

Animals↗

PubMed2025

Genomic Insights Into Convergent Evolution: Adaptation to Rocky Habitats in Rock-Inhabiting Fungi.

Rock-inhabiting fungi (RIF), obligate colonizers of bare rocks, are primarily distributed across two major phylogenetic classes: Dothideomycetes and Eurotiomycetes. These fungi display striking convergence in morphology and physiology, characterized by meristematic growth, melanized cell walls, and extreme stress tolerance. However, the genomic underpinnings of this adaptive convergence remain poorly understood. Here, through comparative genomic analysis of 9 RIF and 18 non-RIF fungi, we revealed that RIF possess compact, gene-dense genomes marked by contraction of genes involved in nutrient uptake and secondary metabolism, alongside expansions in cell wall biosynthesis, lipid metabolism, and stress-responsive pathways. We identified two genes under positive selection across multiple RIF lineages: Ino80 ATPase (chromatin remodeling) and the ER chaperone BiP (protein folding). Further evidence of convergence was found in the mannosyltransferase Mnn9, a key enzyme in cell wall assembly, where two RIF-specific amino acid substitutions were predicted to enhance protein stability. Additionally, a unique Mnn9-like clade has expanded exclusively in RIF. RNAi-mediated knockdown of an Mnn9-like gene in Rachicladosporium sp. confirmed its role in cell wall mannosylation, osmotic stress response, and the transition from meristematic to filamentous growth. Our findings elucidate a set of common genomic adaptations and highlight the specialized evolution of the Mnn9 family in driving the convergent success of phylogenetically diverse RIF in rocky environments.

Phylogeny↗

PubMed2025

The advent of precision nutrigeroscience in cancer: from clinic towards molecular biology.

Nutrimental patterns have been deemed to have an impact on cancer development and the response to cancer therapy. Our growing understanding of cancer and host metabolism has highlighted that nutrient availability in the tumor ecosystem is a key factor in inhibiting tumor development. Subsequently, dietary interventions must take into account the specific characteristics of both the cancer and the host, which requires a detailed understanding of the mechanisms that determine the metabolic vulnerabilities in the tumor ecosystem. In this review, we provide an overview of various dietary regimens as interventions in both preclinical models and clinical studies. We discuss how dietary intervention can affect the homeostasis of the tumor ecosystem, including neoplastic, micro- and macro-environmental states that impact cancer progression and therapy. Our emphasis is on the prospects of precision nutrigeroscience, which involves developing individualized therapeutic approaches and predictors based on a thorough exploration of the mechanisms and critical factors. This approach has the potential to enhance the efficacy of anti-cancer treatments and prevention strategies.

Humans↗